POS-459 Immunofluorescence Staining for Immunoglobulin Heavy Chain/Light Chain on Kidney Biopsies is a Valuable Ancillary Technique For the Diagnosis of Monoclonal Gammopathy-Associated Nephropathies
S. Nasr, S. Said, M. Fidler and 1 more
Kidney International Reports · 2021
doi:10.1016/j.ekir.2021.03.485 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Heavy chain/light chain (HLC) antibodies target conformational epitopes at the junctions of the heavy chain and light chain constant regions (CH1 and CL) of serum IgGκ, IgGλ, IgAκ, IgAλ, IgMκ, and IgMλ to provide quantitation of intact HLC pairs. This assay is currently approved for the measurement of clonal expansion and monitoring of patients with multiple myeloma, and has been shown to have a prognostic utility. To our knowledge, the use of HLC antibodies in renal pathology has not tested.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.